Time line for trails is annoying for scar application thought this would be first off the ground with liver scarring etc down the line but seems its promising. Far more promising then their last headline product. Good IP protection too.
- Forums
- ASX - By Stock
- SNT
- Ann: PXS Announces Encouraging Results from Phase 1c Scar Study
Ann: PXS Announces Encouraging Results from Phase 1c Scar Study, page-8
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.65M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 519110 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 131428 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 519110 | 0.022 |
5 | 1736248 | 0.021 |
11 | 3131008 | 0.020 |
2 | 700000 | 0.019 |
3 | 997999 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 131428 | 2 |
0.025 | 150000 | 2 |
0.027 | 200000 | 1 |
0.028 | 500000 | 1 |
0.029 | 300000 | 1 |
Last trade - 10.39am 03/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online